Detection of Simultaneous Group Effects in MicroRNA Expression and Related Target Gene Sets by Artmann, Stephan et al.
Detection of Simultaneous Group Effects in MicroRNA
Expression and Related Target Gene Sets
Stephan Artmann
1., Klaus Jung
1., Annalen Bleckmann
1,2, Tim Beißbarth
1*
1Department of Medical Statistics, University Medical Center Go ¨ttingen, Go ¨ttingen, Germany, 2Department of Hematology and Oncology, University Medical Center
Go ¨ttingen, Go ¨ttingen, Germany
Abstract
Expression levels of mRNAs are among other factors regulated by microRNAs. A particular microRNA can bind specifically to
several target mRNAs and lead to their degradation. Expression levels of both, mRNAs and microRNAs, can be obtained by
microarray experiments. In order to increase the power of detecting microRNAs that are differentially expressed between
two different groups of samples, we incorporate expression levels of their related target gene sets. Group effects are
determined individually for each microRNA, and by enrichment tests and global tests for target gene sets. The resulting lists
of p-values from individual and set-wise testing are combined by means of meta analysis. We propose a new approach to
connect microRNA-wise and gene set-wise information by means of p-value combination as often used in meta-analysis. In
this context, we evaluate the usefulness of different approaches of gene set tests. In a simulation study we reveal that our
combination approach is more powerful than microRNA-wise testing alone. Furthermore, we show that combining
microRNA-wise results with ‘competitive’ gene set tests maintains a pre-specified false discovery rate. In contrast, a
combination with ‘self-contained’ gene set tests can harm the false discovery rate, particularly when gene sets are not
disjunct.
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Introduction
Biological Background and Motivation
Interest in microRNAs (miRNAs) has been continuously
growing in recent years [1]. They regulate gene expression and
play a role in a wide spectrum of biological fields, ranging from
developmental to tumour biology [2]. Their function is to regulate
gene expression by down-regulation of mRNAs. The gene
transcripts get either directly degraded or their translation is
inhibited. This gives reason to search for differentially expressed
miRNAs between two different groups of biological samples,
which was widely done for mRNAs in the past.
While the exact mode of miRNA action is still under
investigation, more and more details of the mechanism of
miRNA-mediated inhibition of gene expression are being discov-
ered. It is known, for instance, that their precursors are transcribed
in the nucleus. After several processing steps and the export into
the cytoplasm a mature miRNA is incorporated into the RNA-
induced silencing complex, referred to as ‘RISC’. This protein
complex affects the levels of gene expression, while the miRNA
itself only acts by guiding the complex to mRNAs based on
sequence homology. Consequently, each miRNA has a set of
target mRNAs defined by the sequence of both. The target set is
supposed to be more or less unique for each miRNA. However,
the target sets of two miRNAs need not necessarily be disjunct.
The sequence dependent specificity of miRNAs for their target
gene sets can be predicted. Several databases of such predicted
target sets have been established, for example ‘microCosm’ [3]
and ‘TargetScan’ [4]. Additionally, databases of experimentally
validated miRNA-targets exist [5].
Expression levels of both, mRNA-targets and miRNAs, can be
detected in a high-throughput manner. Microarrays have been
used in the last decade to measure RNA levels. They have been
adopted for miRNAs as well and are gaining popularity [6,7].
The above-mentioned sources of information, i.e. the
available links between miRNAs and their related target gene
sets through databases as well as observed expression levels
through microarray experiments, can provide a close view of a
cell’s, tissue’s or organism’s miRNA status. However, searching
for differentially expressed miRNAs, has mainly concentrated on
miRNA-wise testing so far. In the case that researchers took
miRNA target sets into account, this was primarily done
separately from miRNA analysis. Mostly, only those target sets
were studied whose miRNAs were already detected as
differentially expressed. These current approaches can, however,
lead to more false positives or negatives than necessary. Assume,
for example, a particular miRNA that is highly expressed under
a certain condition but whose target mRNAs are absent in a
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38365cell anyway. The effect on the cell’s phenotype of such a
miRNA can be expected to be rather small. Vice versa, due to
the enzymatic function of the RISC complex, little changes in
miRNA levels can lead to large effects in their targets’ levels.
Thus, many interesting features can be missed when informa-
tion about target gene sets are omitted.
In order to increase the power of detecting differentially
expressed miRNAs in the two-group design, the aim of this work
is to combine miRNA- and mRNA-expression data. More
precisely, we present and evaluate an approach to detect pairs of
miRNAs and related target sets of mRNAs that simultaneously
exhibit a group effect. Our approach is to first analyse miRNA and
mRNA expression data separately, and then to combine the
resulting information. All software used and implemented is
written in the R statistical programming language [8].
Gene-wise and Gene Set Testing
One approach to detect group effects in miRNA expression
data is to perform component-wise statistical tests. Each test
analyses whether a particular miRNA is differentially expressed
between the two groups. A large number of methods exists, for
example mixture models [9], permutation tests [10], empirical
Bayes approaches [11] and analysis of variance models [12].
Here, we employ a widely used linear model implemented in
the R-package ‘limma’ which makes use of empirical Bayes
methods [13].
Group effects in the related target gene sets are not studied by
individually testing each component of a set. Instead, the group
effect is assessed globally for a whole set. Different statistical
approaches of gene set tests have been proposed which can be
divided into ‘self-contained’ and ‘competitive’ tests [14]. The self-
contained approaches incorporate only expression levels of the
genes of a particular set. As self-contained methods we will employ
and compare so called global tests as well as a rotation-based
procedure. Competitive approaches, on the other hand, incorpo-
rate the expression levels of all genes within a microarray
experiment. ‘Gene Set Enrichment Analysis’ (GSEA) [15], for
example, studies the distribution of ranks of differentially expressed
genes from the target gene set using a weighted form of the
Kolmogorov-Smirnov test.
Component-wise testing of miRNAs and simultaneous testing of
related target gene sets yields two lists of p-values. In order to
detect which (miRNA, gene set)-pairs possess a simultaneous
group effect we propose a new approach. In particular, we employ
methodology frequently used in the field of meta analysis to
combine p-values from different experiments. Such methods were
already used for gene expression data, however, in a different
context than ours, for example to combine microarray results from
different experimental stages [16]. A flow chart of our approach is
depicted in Figure 1. The combined p-values are finally translated
into a score.
In the following paragraph we detail the methods for
component-wise testing, gene set testing and p-value combination.
Subsequently we show the results of a simulation study. In this
simulation study we determined the false-discovery rate (FDR), i.e. the
portion of false positive detections among all positive test results,
with regard to simultaneous group effect of miRNAs and related
target gene sets. Additionally, we determined the average power rate
(APR), i.e. the portion of all true positive detections. Besides, we
evaluate the performance of our combination approach on one
example of mouse expression data and one of expression in HIV
samples. Finally, the results are discussed.
Methods
MicroRNA-wise Testing
For miRNA-wise testing we apply the linear models proposed
by [13]. They can generally be used for analysing gene expression
data in dependence from several experimental factors. In the
particular design we are studying here, i.e. one group factor with
two levels, the group effect of gene i (i~1,:::,dmicro) can be denoted
by bi in these models. Consequently, the related model tests
separately for each gene the null hypothesis of no group effect, i.e.
H0i : bi~0.
According to [13], because of the large number of hypotheses,
these are tested by moderated t-type statistics. These test statistics
are based on the fact that for some features a very small variance is
expected although the related difference of group means is rather
small. Thus, the ordinary t-statistic would become unreasonable
large for these features. The moderated t-statistic is calculated by
incorporating a prior distribution for the standard deviations of the
components and shrinking the observed standard deviation to
these prior values. In our simulations and data analyses, we use the
R-package ‘limma’ to test each individual hypothesis by the
moderated t-statistic, obtaining one p-value per miRNA.
Gene Set Testing
Self-contained methods. In order to test the group effects
within the target mRNA sets, we use different so called global tests.
Each of them forms a self-contained method, since only the
Figure 1. Flow chart of combining expression levels of miRNAs
and their related target mRNAs. The links between microRNAs and
their target mRNAs are taken from public databases. MicroRNAs and
target sets are first analysed separately and obtained p-values are
combined as final result.
doi:10.1371/journal.pone.0038365.g001
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microarray experiment are used. The first one is the ‘globaltest’
procedure proposed by [17]. This procedure is based on a logistic
regression model. Thus, the group factor exhibits a dichotomous
response parameter G[f1,2g and one tests the null hypothesis that
the group membership is independent from the gene expression,
i.e. H0i : P½GDYi  = P½G . Here, Yi denotes the matrix of
expression levels for the ith target gene set. The test statistic for this
model is asymptotically normally distributed. For large sample
sizes a sample permutation approach is offered as well. Another
approach (‘GlobalAncova’) was proposed by [18] and improved by
[19]. This approach uses an ANCOVA-model testing the reverse
null hypothesis, i.e. that the gene expression is independent from
the group membership. This hypothesis can be formulated by
H0i : P½YiDG~1  = P½YiDG~2 . This approach also offers an
asymptotic result and a permutation algorithm as well. The third
approach of global testing is a general model for high-dimensional
repeated measures data [20,21], in the following referred to as
‘RepeatedHighDim’. This approach tests the same hypothesis as
‘GlobalAncova’. All three approaches, ‘globaltest’, ‘GlobalAncova’
and ‘RepeatedHighDim’ are implemented in R-packages of the
same names.
As another self-contained method, we regard the ‘ROAST’ test
proposed by [22] also implemented in the R-package ‘limma’. In
this approach, the data is modelled similarly to the above-detailed
models of [13]. The moderated t-statistics are calculated mRNA-
wise and transformed to standard normal variables. A gene set
statistic is then calculated by summarizing the mRNA-wise
statistics. Here we use the unweighted mean of the t-statistics.
To account for inter-gene correlations, random rotations [23] are
applied and an exact p-value is calculated.
Competitive methods. The competitive gene set methods
we investigate are similar to GSEA proposed by [15]. Using data
from a whole microarray experiment we employ again the models
of [13] ‘limma’-package to produce mRNA-wise p-values with
regard to differential expression. A rank is assigned to each mRNA
according to the position of its p-value. Three different enrichment
tests are applied to analyse the distribution of ranks belonging to a
particular gene set. The first one is the one-sided Kolmogorov-
Smirnov test. It is used to test the null hypothesis that the ranks of
the genes inside the gene set come from a uniform distribution.
The alternative is that the distribution of the genes in the gene set
is skewed towards lower ranks. As second approach, the two-
sample Wilcoxon test is applied on gene ranks. It compares the
distribution of ranks inside and outside the gene set. Finally, a
method using a 262-contingency table is employed. In particular,
Fisher’s exact test is employed to compare the proportion of
differentially expressed genes among the gene set with the
proportion of differentially expressed genes outside the gene set.
In addition, we employ a rotation test, that is the competitive
‘Romer’ test [24]. It is similar to the above-mentioned ‘ROAST’
test, but it is competitive in that it compares gene sets. For both
tests we set the number of rotations to 1000 to be able to produce
p-values as low as 10{3.
Combination of p-values
While component-wise testing yields one p-value per miRNA,
gene set testing yields one p-value for each of the related gene sets.
We use methodology often used in meta analysis to bring this
information together. The behaviour of a miRNA and its related
gene set is usually supposed to be inverse, i.e. up-regulation of a
particular miRNA is supposed to cause a down-regulation of the
related gene set. Accordingly, we are particularly interested in
detecting these cases in our data analyses. Therefore, we perform
gene set testing in a one-sided way, one time in each direction. We
denote the p-values for the alternative hypotheses of up- and
down-regulation of an miRNA by pmicro: and pmicro;, respectively.
The related p-values for up- and down-regulation of a target gene
set are denoted by ptarget: and ptarget;, respectively.
One-sided hypotheses can be tested for the competitive
enrichment tests, i.e. for the Kolmogorov-Smirnov, the Wilcoxon
and Fisher’s exact test. One-sided testing is also possible for the
two rotation test, i.e. for the competitive Romer and the self-
contained ROAST test. The hypotheses for the three self-
contained global tests, i.e. globaltest, GlobalAncova and Repea-
tedHighDim, however, can not be reasonably stated in a one-sided
way. Therefore, we split the target gene sets when using these
global procedures and test the two sets of up- and down-regulated
genes separately. The direction of regulation is determined for
each gene by comparison of group means. It should be mentioned
that this approach for the self-contained tests may introduce some
bias as the observed data itself is used for the prior partitioning.
However, the results of our simulations below show that our
methods yet maintain a prespecified FDR in most situations.
For the combination of p-values we distinguish two cases. For
the two rotation tests as well as for the Wilcoxon test the target p-
values for up- and down-regulation (approximately for the rotation
tests) sum up to one, i.e. ptarget:zptarget;~1. In this case we use
Stouffer’s inverse normal method [16,25] to combine p-values. For
all other gene set tests in most cases we obtain ptarget:zptarget;=1,
and we will use Fisher’s combination method then [26]. In both
cases, we first combine pmicro and ptarget, separately for up- and
down-regulation, and derive then a final score based on the two
combined p-values. The final results should rather be regarded as
scores than as a p-values, although these scores range from zero to
one. The calculation of the scores is described in the following.
Fisher’s combination method. Because our primary goal is
to detect differentially expressed miRNAs using the additional
information about their target’s regulation, and because we
assume miRNA and target regulation to be inverse, we combine
the miRNA’s p-value of up-regulation with the target’s p-value for
down-regulation and vice versa. According to Fisher’s method, the
combined p-values for the ith miRNA are given by
p
combined:
i ~1{Fx2 {2: ln(p
micro:
i )zln(p
target;
i )
     
and
p
combined;
i ~1{Fx2 {2: ln(p
micro;
i )zln(p
target:
i )
     
,
where Fx2(q) is the q%-quantile of the x2-distribution with four
degrees of freedom.
In order to obtain a decision value between zreo and one, we
build as final score
Si~min 2:min(p
combined:
i , p
combined;
i ),1
  
:
Stouffer’s inverse normal method. According to Stouffer’s
inverse normal method the combination is performed as follows:
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where W is the cumulative distribution function of the standard
normal distribution. Here, we derive the final score by
Si~max p
combined:
i , p
combined;
i
  
:
Note that when Stouffer’s method is applied for the Wiloxon-
test as the gene set testing procedure, the scores
Si~p
combined:
i ~p
combined;
i can be regarded as p-values [16]. For
the rotation tests, we obtain ptarget:zptarget;~1 only approxi-
mately for large numbers of rotations. As a consequence, [16] Si
for rotation tests is always more conservative than a p-value would
be.
Simulation Study
In order to evaluate whether the above-detailed methods are
applicable to detect simultaneous group effects in miRNA and
target mRNA expression data, simulation studies that picture the
two group design were performed. The numbers of biological
replicates per group were set to be n1~n2~4. Thus, a total
number of N~8 samples was produced per simulation run. The
numbers of simulated miRNAs and mRNAs was dmicro~100 and
dmess~1000, respectively. Expression data were stored in matrices
with columns representing samples and rows representing either
miRNAs or mRNAs. Data generation was performed as follows.
Expression levels were drawn from multivariate normal
distributions N dmicro and N dmess, respectively. Mean vectors were
drawn from a log-normal distribution and covariance matrices
were chosen to have either a block structure, an autoregressive
structure or to be of an unstructured type. To generate
differentially expressed features 10% of miRNAs and 5% of
mRNAs were randomly selected. Half of these features was up-
regulated by adding a log fold change of d to the corresponding
mean vector while the other half was down-regulated by
subtracting d.
In order to model the effect of miRNAs on mRNA degradation
a (dmicro|dmess) allocation matrix A was constructed that defined
the targets of each miRNA. Each entry aji of A took on the value 1
if miRNA i was designated to attack mRNA j (j~1,:::,dmess), and
the value 0 otherwise. Different structures of A were compared in
order to simulate non-overlapping and non-oberlapping gene sets,
respectively.
The miRNA effect on mRNA expression levels was constructed
by a simple linear model. Denote nraw
kj to be the jth entry of the
mean vector for the mRNAs in group k (k~1,2), as constructed
above. Furthermore, denote mki to be the ith entry of the mean
vector for the miRNAs of the same group. The modifications of
the mean vectors n of the mRNA were then modelled in
dependence of the mean vectors m of the miRNAs using the
following equation:
n
modified
kj ~nraw
kj z
X dmicro
i~1
aji:bji:mki,
where bji reflects the strength of the modification. The indicator
variables aji are taken from the allocation matrix A. The
modification factors bji were drawn from univariate normal
distributions. The modified expectation vectors nmodified were next
used to draw the expression levels of the mRNAs.
In each of 1000 simulation runs expression data were drawn as
described above, and the different methods for miRNA-wise
testing and gene set testing were carried out. Scores were
constructed from the resulting combined p-values. After adjusting
the scores for multiple hypothesis testing according to [27] the
FDR and the APR were determined in each simulation run. For
all simulated FDRs we evaluated whether they maintain a
predefined level of 5%.
Pathway Analysis of Data Examples
In the analysis of the data examles below, we searched for
enriched gene ontology-terms (GO-terms) in order to evaluate
which functional role the newly predicted miRNAs play in studied
biological context. GO-terms were aquired via the R-packages
‘biomaRt’. For the miRNAs of interest, GO-analysis counts the
occurence of terms among the related target genes and compares
this to the count in the genes of the not in the target set. The
counts are compared between target genes and non-target genes
by means of Fisher’s exact test.
Results
Simulated False-discovery Rates
In each simulation setting, the FDR was separately determined
1) for using only the miRNA-wise testing procedure, 2) for using
only the testing procedures of the related target gene sets and 3) for
using the approach of combined p-values. In each of the three
variants, the FDR was regarded as the portion of false positively
detected miRNAs among all positively detected miRNAs. An
overview of the obtained FDR under all simulation conditions for
the two latter approaches is given in Tables 1 and 2. No systematic
effect could be observed with regard to the different covariance
matrices. While the miRNA-wise testing maintained the pre-
specified FDR-level of 5% within an acceptable range, target set
testing and combined testing sometimes exceeded this level. This
happened only sometimes for competitive tests, but quite often
when self-contained ones were applied.
Non-overlapping gene sets. In the case of non-overlapping
target gene sets, the approach of miRNA-selection based on target
set testing became too liberal in many cases when the self-
contained tests were applied. In comparison the FDR was rather
conservative when competitive tests were employed.
A similar result can be observed when selecting miRNAs by
combined testing. With this approach the ‘ROAST’ and ‘Romer’
method behave very well, yielding simulated FDRs of 0.032–0.053
and 0.031–0.047, respectively.
Overlapping gene sets. Allowing target gene sets to be
overlapped increased the simulated FDR in most of the
simulations. Exemplarily, this effect is illustrated in Figure 2 for
the Wilcoxon based target set testing (top) and the ‘globaltest’
approach (bottom), where the obtained FDR is plotted versus an
increasing log fold change. Particularly ‘globaltest’ was very strong
affected by letting target sets being overlapped. The FDR
Group Effects in MicroRNAs and Target Gene Sets
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about 90 %, then.
This strong effect could also be observed for the other self-
contained tests except for ‘ROAST’. In comparison, the compet-
itive tests still maintained the pre-specified 5%-level in most cases
of overlapping target sets. Here, the largest FDR observed was
0.08 (combined testing with the Wilcocon approach).
Simulated Average Power Rates
In our simulation study the average power rate of each
approach was the portion of true positive detected miRNAs
among all positives detected miRNAs. Table 3 compares the
power rate curves of 1) component-wise miRNA testing, 2) target
gene set testing and the 3) combination approach in the different
simulation settings. Although, the power curves sometimes
intersected, this table gives the general tendency of the relations
between the three approaches.
Non-overlapping gene sets. In most cases of non-overlap-
ping gene sets, component-wise testing of miRNAs resulted in the
lowest APR, compared to simultaneous testing of the related
target gene sets or to the combination approach. Among the latter
two approaches, the combination approach mostly yielded the
largest power. In some cases, however, pure gene set testing
yielded the largest power: as a typical example, the left-hand side
of Figure 3 compares the APR for component-wise miRNA
testing, for gene set testing using the ‘ROAST’ method and for the
p-value combination method.
Overlapping gene sets. In the case of overlapping target
gene sets the performance of competitive combined testing was not
seriously affected. For some self-contained tests, however, the
combination-approach became worse than testing target sets
alone. MiRNA-wise testing, however, was outperformed by the
two other approaches in each case.
General comparison of APR. Most often the algorithms
based on competitive gene set tests had a higher APR than those
based on self-contained tests. The same is true when the
performance of the gene set tests on their own is compared.
Comparing directly the gene set tests among each other, they
sometimes varied greatly (see Table 4). In general, combined
testing based on Wilcoxon and Kolmogorow-Smirnov tests had a
better performance than the rest. Take Figure 3 on the right for
example. There, the APR of combined miRNA-wise testing and
the Wilcoxon test is clearly higher than for the Romer- and the
ROAST-tests.
Analysis of Neurogenesis Data Example
In a data example of miRNA and mRNA expression in rat
brains [28] we want to illustrate the gain of using the above
detailed combination methods. These example data were obtained
from MIAME compliant databases. In particular, miRNA-data
Table 1. Simulated FDR for microRNA-selection based on target set testing.
Gene set test Covariance matrix Non-overlap. target sets Overlap. target sets
GlobalTest Autoregressive 0.102–0.105–0.139 0.305–0.900–0.900
Block 0.052–0.107–0.124 0.035–0.900–0.900
Unstructured 0.212–0.215–0.617 0.750–0.900–0.900
GlobalAncova Autoregressive 0.000–0.000–0.051 0.04–0.046–0.058
Block 0.002–0.005–0.053 0.028–0.031–0.032
Unstructured 0.000–0.000–0.003 0.000–0.036–0.039
RepeatedHighDim Autoregressive 0.019–0.081–0.083 0.103–0.900–0.900
Block 0.000–0.002–0.011 0.008–0.040–0.049
Unstructured 0.030–0.034–0.037 0.031–0.878–0.900
ROAST Autoregressive 0.068–0.074–0.077 0.091–0.892–0.900
Block 0.082–0.088–0.100 0.065–0.846–0.900
Unstructured 0.000–0.002–0.041 0.043–0.046–0.049
KS Autoregressive 0.002–0.005–0.036 0.029–0.031–0.036
Block 0.000–0.000–0.003 0.003–0.036–0.040
Unstructured 0.029–0.031–0.033 0.030–0.730–0.900
Wilcoxon Autoregressive 0.001–0.002–0.009 0.010–0.030–0.039
Block 0.026–0.029–0.035 0.038–0.882–0.900
Unstructured 0.074–0.079–0.111 0.114–0.893–0.900
Fisher Autoregressive 0.105–0.110–0.178 0.102–0.862–0.900
Block 0.000–0.001–0.056 0.042–0.047–0.050
Unstructured 0.002–0.004–0.049 0.029–0.030–0.033
Romer Autoregressive 0.000–0.000–0.003 0.003–0.038–0.040
Block 0.023–0.025–0.031 0.033–0.741–0.900
Unstructured 0.000–0.002–0.007 0.005–0.027–0.033
Simulated FDR with respect to the type of gene set test and covariance matrix using the approach of selecting microRNAs by testing their target gene sets. Results are
presented for the simulation setting of overlapping and disjunct target sets. Presented numbers are the minimum, median and maximum simulated FDR across the
range of the log fold change d (between 0 and 6). Rates larger than the pre-specified level of 0.05 are printed in bold.
doi:10.1371/journal.pone.0038365.t001
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MEXP-1596), the corresponding preprocessed mRNA-data were
downloaded from ‘Gene Expression Omnibus’ [30] (GEO
accession number: GSE11334). Expression data was subsequently
log-transformed and normalised using the quantile method [31].
Data from ‘TargetScan 4.19 [4] was used to create the allocation
matrix A.
The example data contains miRNA and mRNA expression
profiles from neuronal progenitors isolated from rat brains at
embryonic day 11 (E11) and embryonic day 13 (E13). Three
animals per group were sacrificed for miRNA arrays while 4
biological replicates were taken for mRNA profiling. Here we will
compare expression profiles of early neuronal progenitors (ENPs)
in E11 and E13 samples.
Table 5 lists the miRNAs originally detected by Nielsen et al.
[28] and the results of our reanalysis. The listed miRNAs were
reported to be either significantly up- or down-regulated (column
1) with a log fold change larger than 2. For the differential
miRNAs, the authors also determined target gene sets with more
genes differentially expressed than expected by chance using
Fisher’s exact test. This was separately done for up- and down-
regulated subsets of each target set (columns 3 and 4). For 20 of
the listed miRNAs Nielsen et al. find lower p-values for the subset
of inversely regulated target genes than for those regulated in the
same direction as the miRNA, just as one would expect for gene
sets attacked by a miRNA. Twelve of the listed miRNAs have a
significantly inversely regulated target set according to Nielsen et
al.
For our re-analysis data of 223 miRNAs were available, where
202 of them were associated with a target gene set of at least two
mRNAs (according to the ‘TargetScan’ 4.1 database). We applied
our different approaches to the expression levels of these 202
(miRNA, target set)-pairs.
Results of our re-analysis are also included in Table 5. The
uppermost listed 18 miRNAs were determined significant by our
combination approach based on either the global tests, the
enrichment tests or the rotation tests (columns 5 to 7).
The following listed five miRNAs were not detected by our
rotation test-based combination approach, but by the approaches
based on global tests and enrichment tests. One of these five, miR-
218, even had a gene set differential in the same direction as the
miRNA in the original publication.
Among the four bottom-listed features, miR-19a, miR-210 and
miR-126 were significant by our global test- and enrichment test-
based approach but only by one of the two rotation-based methods
(either ‘Romer’ or ‘ROAST’). We add, that these miRNA also had
only a weak fold change.
Out of the miRNAs originally detected by Nielsen et al., miR-
290 got the lowest number of procedures to declare it significant in
our re-analysis. Indeed, in their original analysis the authors point
out that its target gene set tended to be regulated in the same
direction as the miRNA itself.
Table 2. Simulated FDR for microRNA-selection based on combined target set and microRNA-wise testing.
Gene set test Covariance matrix Non-overlap. target sets Overlap. target sets
GlobalTest Autoregressive 0.069–0.074–0.095 0.149–0.900–0.900
Block 0.064–0.069–0.071 0.120–0.900–0.900
Unstructured 0.178–0.183–0.524 0.693–0.900–0.900
GlobalAncova Autoregressive 0.029–0.033–0.062 0.044–0.046–0.062
Block 0.043–0.045–0.063 0.034–0.036–0.045
Unstructured 0.005–0.006–0.006 0.007–0.037–0.042
RepeatedHighDim Autoregressive 0.044–0.047–0.053 0.058–0.318–0.576
Block 0.031–0.034–0.047 0.029–0.037–0.044
Unstructured 0.033–0.038–0.044 0.027–0.680–0.900
ROAST Autoregressive 0.045–0.048–0.057 0.035–0.754–0.900
Block 0.095–0.105–0.127 0.075–0.814–0.900
Unstructured 0.033–0.036–0.057 0.049–0.051–0.055
KS Autoregressive 0.052–0.054–0.061 0.036–0.044–0.045
Block 0.010–0.012–0.013 0.013–0.047–0.049
Unstructured 0.037–0.040–0.044 0.025–0.036–0.046
Wilcoxon Autoregressive 0.039–0.044–0.058 0.037–0.039–0.046
Block 0.026–0.029–0.036 0.030–0.704–0.900
Unstructured 0.042–0.050–0.060 0.054–0.791–0.900
Fisher Autoregressive 0.111–0.119–0.211 0.120–0.838–0.900
Block 0.031–0.034–0.052 0.044–0.049–0.080
Unstructured 0.045–0.050–0.059 0.039–0.043–0.054
Romer Autoregressive 0.007–0.008–0.012 0.012–0.044–0.047
Block 0.032–0.034–0.043 0.028–0.039–0.052
Unstructured 0.038–0.041–0.046 0.033–0.036–0.063
Simulated FDR with respect to the type of gene set test and covariance matrix using the approach of combined target set and microRNA-wise testing. Results are
presented for the simulation setting of overlapping and disjunct target sets. Presented numbers are the minimum, median and maximum simulated FDR across the
range of the log fold change d (between 0 and 6). Rates larger than the pre-specified level of 0.05 are printed in bold.
doi:10.1371/journal.pone.0038365.t002
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significant in all tests applied. All of these were also differentially
expressed according to miRNA-wise testing. ‘Romer’, as a rather
conservative test, detected just three more miRNAs, ‘ROAST’
already 25, the ‘KS’, W’- and ‘Fisher’-based Tests 36, 45 and 76,
respectively, and the Global Test-based procedures showed a
rather liberal behaviour. The ‘globaltest’, ‘GlobalAncova’ and
‘RepeatedHighDim’-based methods detected all but 31, 34 and 35
miRNAs, respectively.
Our GO-analysis (see Table 6) for the eighteen additional
miRNAs detected by all approaches returned 285 (out of 12225)
GO-terms that were significantly correlated with the related
target sets. Among the top scoring GO-categories mainly terms
regarding transcription were detected, however other terms
concerning the topic under investigation appear as well.
Especially, we find terms related to transcription factor activity
(e.g. ‘sequence-specific DNA binding transcription factor activ-
ity’, ‘regulation of transcription, DNA-dependent’, ‘positive
regulation of transcription from RNA polymerase II promoter’
among the top three terms), related to development (e.g. ‘growth
factor binding’, ‘anterior/posterior pattern specification’ or ‘in
utero embryonic development’ on positions 11, 15, 16), and
related to neurogenesis (e.g. ‘axon guidance’ and ‘axonogenesis’
Figure 2. Effect of overlapping target gene sets on the simulated FDR. Effects are presented for component-wise testing (dotted line),
target set-wise testing (dashed line) and the combination approach (solid line). While the competitive approaches such as the ‘Wilcoxon’-based gene
set test (top) still maintained the pre-specified FDR-level of 5% when target gene sets overlapped, the FDR increased dramatically when employing
the self-contained approaches such as the ‘globaltest’ procedure (bottom).
doi:10.1371/journal.pone.0038365.g002
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development of neurons.
Analysis of HIV Data Example
For further evaluation of our proposed methods we apply them
on another example of parallel mRNA and miRNA data. In
particular, we analyse data published by Gupta et al. [32] who
compared normal primary peripheral blood mononuclear cells to
such infected with HIV. Their miRNA and mRNA are available
from GEO (accession numbers: GSE33877 and GSE33837).
In this dataset, the rather conservative yet reliable rotation-test-
based approach fails to find any miRNAs, i.e. there were no FDR-
adjusted scores ƒ0:05, while self-contained tests returned large
numbers of significant miRNAs. Therefore, we rely in the
Table 3. Relation between simulated power rate curves.
Gene set test Covariance matrix Non-overlap. target sets Overlap. target sets
Globaltest Autoregr. miRNA , set < combined miRNA , set < combined
Block & unstr. miRNA , set , combined miRNA , combined , set
GlobalAncova Autoregr. miRNA , set , combined miRNA , set < combined
Block & unstr. miRNA , set , combined miRNA , combined , set
Rep’HighDim Autoregr. miRNA , set < combined miRNA , set < combined
Block & unstr. miRNA , set < combined miRNA , set , combined
ROAST Autoregr. *miRNA , combined , set miRNA , combined , set
Block miRNA < set , combined miRNA , combined , set
Unstr. miRNA < set , combined miRNA , set < combined
KS Autoregr. miRNA , set , combined miRNA , set , combined
Block & unstr. miRNA , set # combined miRNA , set , combined
Wilcoxon Autoregr. miRNA , set , combined miRNA , set , combined
Block & unstr. miRNA , set # combined miRNA , set , combined
Fisher Autoregr. miRNA , set , combined miRNA , set , combined
Block & unstr. miRNA , set # combined miRNA , set , combined
Romer Autoregr. miRNA , combined , set miRNA , combined , set
Block & unstr. set , miRNA , combined set , miRNA , combined
Relation between simulated power rate curves of microRNA-wise, target set-wise and combined testing. Although, power curves sometimes intersected, this table gives
the general tendency of the relations between the three approaches. *Compare Figure 3 left.
doi:10.1371/journal.pone.0038365.t003
Figure 3. Simulated average power rates with respect to the log fold change d. Left: component-wise testing (dotted line), target testing
with ‘ROAST’ (dashed line) and the combination approach (solid line), each in the case of an autoregressive covariance structure and non-overlapping
target sets. Right: combination approach based on ‘globaltest’ (dotted line), ‘Wilcoxon’ (dashed line) and ‘Romer’ (solid line), each in the case of an
unstructured covariance matrix and overlapping target sets.
doi:10.1371/journal.pone.0038365.g003
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presented itself to be less conservative than Romer yet still reliable
in our simulation.
Doing so, we found 9 significant miRNAs (hsa-miR-516b, hsa-
miR-639, hsa-miR-503, hsa-miR-191*, hsa-miR-548a-5p, hsa-
miR-300, hsa-miR-369-5p, hsa-miR-431*, and hsa-miR-200a*).
Interestingly, these do not overlap with the miRNAs that were
reported to be differential by Gupta et al. However, looking at the
GO-terms (Table 6) associated with the target genes of these 9
miRNAs similar categories as originally reported appear. These
are mainly cell cycle and transcription activity, such as ‘S Phase’,
‘nucleosome’, ‘nucleoplasm’ or ‘nucleosome assembly’ in the top
ranks, but also ‘telomere maintenance’ which is rather apoptosis-
related. Besides, terms related to blood cell functions (‘negative
regulation of megakaryocyte differentiation’ and ‘blood coagula-
tion’) appear.
Discussion
Studies on the molecular aspects of a wide range of diseases now
focus on relations between mRNA and miRNA expression.
Besides the two above-analysed examples, parallel expression
levels of both types of molecular features were also studied in
studies on colorectal cancer [33], medulloblastoma [34] or colon
polyps [35]. In a large simulation study we show that combining
high-throughput miRNA and mRNA expression data improves
the power of testing either data type individually. In most
simulation settings, combined testing yielded higher power rates
than classical miRNA-wise testing or target set testing alone.
Apart from that, the threat of false positives in gene set testing is
lowered by our approach. In particular, the liberal behavior of the
global tests is somewhat diminished by the combination approach.
However, their self-contained character leads still to many false
positives, especially in the case of overlapping gene sets. In this
context, it should be remarked that our scores proposed in the
methods section do not allways behave completely like p-values. In
our simulation studies the score based on Stouffer’s method was
approximately uniformely distributed in the interval [0, 1] under
the complete null hypothesis, i.e. when no group effects were
introduced. However, the score was scewed to the left when being
based on Fisher’s method. That means, regarding the score as a p-
value is almost appropriate with Stouffer’s method but leads to
somewhat too concervative results with Fisher’s method. Never-
theless, the proposed scores are a useful tool to rank the studied
miRNAs according to their relation to the experimental grouping
factor. Of course, the application of those procedures that did not
maintain the pre-specified FDR-levels (as shown in Tables 1 and
2) is not recommendable for feature selection. Based on these
findings, our future plans involve the development of some
transformation rules for the scores, so that FDR-procedures also
work for those procedures for which the pre-specified FDR level
was not yet maintained.
In most cases, the competitive approaches deal better with the
problem of overlapping gene sets. The enrichment approaches
remained close to the FDR-level desired to be controlled in our
analyses. Naturally, they are more robust to gene set overlaps. In
our simulations the enrichment-based approaches were also robust
to the inter-gene correlations, i.e. they behaved similar under the
different correlation structures we simulated. Nevertheless, one
should keep in mind that under certain correlation structures their
p-values may become skewed even under the null hypothesis. A
simple solution would be to apply a sample permutation
procedure, given that, unlike in our simulations and data example,
there are enough replicates to show low p-values.
The rotation-tests control the FDR in a non-overlapping gene
set context. Otherwise, they profit from the combination in that
they control the FDR better than the respective gene set tests –
‘Romer’-based combined testing even controlled the FDR in all
our simulations. To achieve this they lose power, however.
By applying our procedure on real microarray data we show its
usability in everyday research. Especially the rotation test-based
procedures are able to differentiate between miRNAs which were
differentially expressed with little result in their gene set and others
that lead to differentially expressed targets. For miR-290, for
example, they successfully included the information from the
miRNA’s gene set. There, they were able not to detect a miRNA
which has little effect on its target gene set.
Furthermore, many new miRNAs were detected. Even for the
most conservative procedure 21 further miRNAs were found to
show an effect between E11 and E13. Since we have shown in our
simulations that our combination approach maintains a pre-
specified FDR in most cases, we belief that most of our positive
findings in the data example are true positives. Therefore, we
regard it as an improvement that we find more significant
miRNAs by our combination approaches than were found in the
original analysis by miRNA-wise testing alone.
We outlined information combination in two-group testing. To
generalise our approach to three or more groups is not a hard
thing to do. Both ‘limma’ for miRNA-wise testing, as well as the
gene set tests presented can be used for any number of groups or
continuous response variables. Indeed, arbitrary design matrices
have already been implemented in the ‘miRtest’ package.
So far the procedure suggested needs, strictly speaking
independent p-values from miRNA- and mRNA-data. The Fisher-
Table 4. Rating orders of the APR in simulations of combined testing.
Gene sets Covariance matrix GT GA RHD KS W F Ro R
Non-Overlap. Autoregressive 4 5 3 1 1 8 6 7
B l o c k 7 8 4 115 63
Unstructured 7 8 4 1 1 5 6 3
Overlapping Autoregressive 1 1 1 1 1 6 7 8
B l o c k 6 6 4 113 85
Unstructured 7 6 4 1 1 3 8 4
Rating orders are based on the following gene set tests: GlobalTest (GT), GlobalAncova (GA), RepeatedHighDim (RHD), Kolm. Smirnov (KS), Wilcoxon (W), Fisher (F),
ROAST (Ro) and Romer (R). The rank 1 denotes the largest power rate while the rank 8 denotes the worst power rate (comparable APR-curves were given the same
position in the ranking). Note that W and KS always have the largest power rates.
doi:10.1371/journal.pone.0038365.t004
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independent repetitions of experiments. An example for matched
data would be that the same individuals were taken for miRNA
and mRNA microarray analysis. Such designs are not too
infrequent. An idea to cope with that would be to jointly permute
or rotate the expression matrices of miRNAs and mRNAs.
Another point is to include strategies to overcome gene set
overlaps, i. e. the strong positive correlation between the miRNA-
test statistics (to correct for multiple testing according to [36]
appears to be too rigorous and ignores the information one has on
overlaps). Ideas on how to control the FDR with this problem exist
for gene set testing. See for example approaches for the GO graph
in [37] or [38]. It appears worthwile to include such ideas for
miRNA-testing in future work. Finally, apart from p-value
Table 5. Original results and re-analysis of microRNAs in rat
brains.
Original analysis Re-analysis
miRNA miRNA
Targ.
up
Targ.
down
Glob.
tests
Enrich.
tests
Rot.
tests
miR-99a/b up n.s. sig. sig. sig. sig.
miR-9 up n.s. sig. sig. sig. sig.
miR-100 up n.s. sig. sig. sig. sig.
miR-181b/c up n.s. sig. sig. sig. sig.
miR-125a/b up n.s n.s sig. sig. sig.
miR-222 down sig. n.s. sig. sig. sig.
miR-291-3p down sig. n.s. sig. sig. sig.
miR-92 down sig. n.s. sig. sig. sig.
miR-145 down sig. n.s. sig. sig. sig.
miR-183 down sig. n.s. sig. sig. sig.
miR-363-3p down sig. sig. sig. sig. sig.
miR-143 down n.s. n.s. sig. sig. sig.
miR-200b/c down n.s. n.s. sig. sig. sig.
miR-20b down n.s. n.s. sig. sig. sig.
miR-219 down n.s. n.s. sig. sig. sig.
miR-18 down n.s. n.s. sig. sig. sig.
miR-205 down n.s. n.s. sig. sig. sig.
miR-292-3p down n.s. n.s. sig. sig. sig.
miR-218 up sig. n.s. sig. sig. n.s.
miR-7 up n.s. n.s. sig. sig. n.s.
miR-124a up n.s. sig. sig. sig. n.s.
miR-214 down n.s. n.s. sig. sig. n.s.
miR-199a down sig. sig. n.s.
miR-19a down sig. n.s. sig. sig. sig. (R)
miR-210 down n.s. n.s. sig. sig. sig. (R)
miR-126 down n.s. n.s. sig. sig. sig. (r)
miR-290 down n.s. sig. sig. sig. n.s.
MicroRNAs originally detected in expression data from rat brains by Nielsen
et al. [28]. Columns from left to right are the name of the microRNAs, the
originally reported results (columns 2-4) and the results of our re-analysis
(columns 5-7). Nielsen et al. performed their gene set tests separately for
subsets of up- and down-regulated mRNAs yielding two results per gene set.
Our re-analysis was performed by use of the combination approach based on
either global tests, enrichment tests or rotation tests (‘ROAST’ (R), ‘Romer’ (r)).
Significance (sig.) was declared when the FDR-adjusted p-value was v5% and
not significant (n. s.) otherwise.
doi:10.1371/journal.pone.0038365.t005
Table 6. GO-Terms for Data Examples.
q-value GO-Term
Rat Neurogenesis
7.42e-20 sequence-specific DNA binding transcription factor activity
1.71e-17 regulation of transcription, DNA-dependent
6.90e-17 positive regulation of transcription from RNA polymerase II
promoter
8.57e-13 sequence-specific DNA binding
2.92e-12 transcription, DNA-dependent
2.32e-10 negative regulation of transcription from RNA polymerase II
promoter
3.00e-10 zinc ion binding
1.64e-09 axon guidance
1.64e-09 DNA binding
6.79e-09 SMAD binding
1.02e-08 growth factor binding
7.56e-08 negative regulation of transcription, DNA-dependent
2.92e-07 RNA polymerase II core promoter proximal
region sequence-specific DNA binding transcription factor
activity involved in positive regulation of transcription
2.63e-06 positive regulation of transcription, DNA-dependent
4.72e-06 anterior/posterior pattern specification
5.36e-06 in utero embryonic development
7.85e-06 regulation of actin cytoskeleton organization
1.05e-05 ephrin receptor binding
1.37e-05 gastrulation with mouth forming second
1.42e-05 regulation of translation
1.43e-05 regulation of cell-matrix adhesion
1.85e-05 palate development
2.51e-05 transmembrane receptor protein serine/threonine kinase activity
2.99e-05 axonogenesis
HIV-dataset
3.23e-15 S phase
4.21e-14 regulation of gene silencing
1.36e-13 nucleosome
8.53e-12 nucleoplasm
5.86e-11 nucleosome assembly
4.70e-10 negative regulation of megakaryocyte differentiation
3.24e-09 chromosome
1.53e-05 transcription initiation, DNA-dependent
0.0002 telomere maintenance
0.0002 chromatin organization
0.0009 phosphatidylinositol-mediated signaling
0.0025 CenH3-containing nucleosome assembly at centromere
0.0119 gene expression
0.0279 ribonucleoprotein complex
0.0296 blood coagulation
0.0420 protein refolding
0.0487 signalosome
The top-scoring Gene Ontology (GO) terms with lowest p-values (according to
one-sided Fisher’s exact test) of miRNAs’ target sets from Neurogenesis (above)
and HIV (below) data example.
doi:10.1371/journal.pone.0038365.t006
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analysis in the context of combining results from different
microarray experiments. One could for example combine effect
measures like the fold change by means of the inverse normal
method. However, it seems to be not reasonable to employ meta-
analytic methods for combining effect measures, in the context of
our approach, since there is up to now no established measure
describing the up- or down-regulation in the global test setting.
In summary, we developed a method to seek out miRNAs that
show an effect either in their own expression, or in their respective
gene set between two groups. Our method enables researchers to
analyse miRNA data in a more statistical reliable manner than to
test miRNA-expression and mRNA-expression separately. As
miRNAs directly act on their mRNA targets miRNA-mRNA
interactions compose a quite simple bipartite network. Its
incorporation into testing for differential expression via gene set
tests helps to gain power. On the other hand, miRNA expression
data leads to less type I errors.
The algorithm was implemented in the ‘miRtest’ R package
available via CRAN (http://cran.r-project.org). As competitive
approaches performed better in our analyses, we chose the
‘Romer’ gene set test as a default and recommend the Wilcoxon
test for those who want to apply a less time-consuming algorithm.
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